Micro and macro population effects in disease transmission: the case of varicella

Epidemiology and Infection

Volumn 138, Issue 4, 2010, Pages 482-490

  Silhol, R ^a,b   Alvarez, F P ^b   Arena, C ^b   Amoros, J P ^c   Flahault, A ^b,d   Hanslik, T ^b,e   Boelle P Y ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE CORSE   (France)

^d EHESP   (France)

^e HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Household; Infectious disease epidemiology; Paediatrics; Transmission; Varicella zoster

Indexed keywords

ARTICLE; CHICKENPOX; CHILD; CONTROLLED STUDY; DISEASE TRANSMISSION; GEOGRAPHIC DISTRIBUTION; HEALTH HAZARD; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POPULATION EXPOSURE; POPULATION SIZE; POPULATION STRUCTURE; PRIMARY SCHOOL; SCHOOL CHILD; SEROPREVALENCE; VARICELLA ZOSTER VIRUS; AGE; EPIDEMIOLOGY; FAMILY HEALTH; FEMALE; FRANCE; HERPES ZOSTER; INCIDENCE; INFANT; MALE; PRESCHOOL CHILD; RISK FACTOR;

AGE FACTORS; CHICKENPOX; CHILD; CHILD, PRESCHOOL; FAMILY HEALTH; FEMALE; FRANCE; HERPES ZOSTER; HUMANS; INCIDENCE; INFANT; MALE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 77949392141     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809990896     Document Type: Article

References (32)

1. Pinot de Moira A, Nardone A. Varicella zoster virus vaccination policies and surveillance strategies in Europe. Eurosurveillance 2005; 10: 43-45.
2. Nardone A, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007; 25: 7866-7872.
3. Yu AL, et al. Varicella transmission in two samples of children with different social behaviour in the State of Sao Paulo, Brazil. Epidemiology and Infection 2001; 127: 493-500.
4. Brisson M, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiology and Infection 2001; 127: 305-314.
5. Whitaker HJ, Farrington CP. Infections with varying contact rates : application to varicella. Biometrics 2004; 60: 615-623.
6. Fales WT. The age distribution of whooping cough, measles, chicken pox, scarlet fever and diphtheria in various areas in the United States. American Journal of Hygiene 1928; 8: 759-799.
7. Ferguson NM, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005; 437: 209-214.
8. Longini IM Jr, et al. Containing pandemic influenza at the source. Science 2005; 309: 1083-1087.
9. House T, Keeling MJ. Household structure and infectious disease transmission. Epidemiology and Infection 2008; 137: 654-661.
10. Cai TX, Betensky RA. Hazard regression for intervalcensored data with penalized spline. Biometrics 2003; 59: 570-579.
11. Gail M, Benichou J. Encyclopedia of Epidemiologic Methods. Chichester : Wiley, 2000.
12. Snijders TAB, Bosker RJ. Multilevel Analysis : An Introduction to Basic and Advanced Multilevel Modeling. London: Sage Publishers, 1999.
13. Moran PAP. Notes on continuous stochastic phenomena. Biometrika 1950; 37: 17-23.
14. Walter SD. The analysis of regional patterns in health data. I. Distributional considerations. American Journal of Epidemiology 1992; 136: 730-741.
15. Anselin L. Local indicators of spatial association - LISA. Geographical Analysis 1995; 27: 93-115.
16. Pfeiffer D, et al. Spatial Analysis in Epidemiology. Oxford: Oxford University Press, 2008, pp. 208.
17. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna: Austria, 2008.
18. Anselin L. Arizona State University (http://geodacenter. asu.edu/). Accessed 18 January 2009.
19. Bivand R. spdep package (http://cran.r-project.org/ web/packages/spdep/ index.html). Accessed 18 January 2009.
20. Ross AH. Modification of chicken pox in family contacts by administration of gamma globulin. New England Journal of Medicine 1962; 267: 369-376.
21. Heininger U, et al. Reliability of varicella history in children and adolescents. Swiss Medical Weekly 2005; 135: 252-255.
22. Kavaliotis J, Petridou S, Karabaxoglou D. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age. International Journal of Infectious Diseases 2003; 7: 274-277.
23. Bricks LF, et al. Reliability of information on varicella history in preschool children. Clinics 2007; 62: 309-314.
24. Khoshnood B, et al. Seroprevalence of varicella in the French population. Pediatric Infectious Disease Journal 2006; 25: 41-44.
25. Boelle PY, Hanslik T. Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiology and Infection 2002; 129: 599-606.
26. Grenfell BT, Bjornstad ON, Kappey J. Travelling waves and spatial hierarchies in measles epidemics. Nature 2001; 414: 716-723.
27. Seward JF, et al. Contagiousness of varicella in vaccinated cases : a household contact study. Journal of the American Medical Association 2004; 292: 704-708.
28. van Der Zwet WC, et al. Neonatal antibody titers against varicella-zoster virus in relation to gestational age, birth weight, and maternal titer. Pediatrics 2002; 109: 79-85.
29. Pinquier D, et al. Prevalence of anti-Varicella-Zoster virus antibodies in French infants below 15 months of age. Clinical Vaccine and Immunology 2009; 16: 484-487.
30. Kemper JT. Error sources in the evaluation of secondary attack rates. American Journal of Epidemiology 1980; 112: 457-464.
31. Longini IM Jr., et al. Estimating household and community transmission parameters for influenza. American Journal of Epidemiology 1982; 115: 736-751.
32. Rentier B, Gershon AA. Consensus: varicella vaccination of healthy children - a challenge for Europe. Pediatric Infectious Disease Journal 2004; 23: 379-389